Duloxetine Hydrochloride
Duloxetine Hydrochloride is a pharmaceutical drug with 34 clinical trials. Currently 1 active trials ongoing. Historical success rate of 93.3%.
Success Metrics
Based on 28 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
29
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.3%
28 of 30 finished
6.7%
2 ended early
1
trials recruiting
34
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Shugan Dingtong Decoction in the Treatment of Fibromyalgia
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy
A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder
Clinical Trials (34)
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Shugan Dingtong Decoction in the Treatment of Fibromyalgia
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy
A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder
A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Short-term Efficacy of Antidepressant in Patients Underwent TKA
A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder
A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China
An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
A Long-term Study for the Treatment of Painful Diabetic Neuropathy
A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia
A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients
Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI Study
Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 34